Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Hitoshi Matsumoto is active.

Publication


Featured researches published by Hitoshi Matsumoto.


Bioorganic & Medicinal Chemistry | 2000

Synthesis and biological activities of novel antiallergic agents with 5-lipoxygenase inhibiting action

Hiroyuki Nakano; Tsutomu Inoue; Nobuhide Kawasaki; Hideki Miyataka; Hitoshi Matsumoto; Takeo Taguchi; Naoki Inagaki; Hiroichi Nagai; Toshio Satoh

Novel benzimidazole derivatives were synthesized and their pharmacological activities were examined. These compounds showed a good suppressive action on histamine release from rat peritoneal mast cells produced by antigen-antibody reaction, an antagonistic action on guinea pig ileum contraction caused by histamine, an inhibitory action on 5-lipoxygenase in rat basophilic leukemia-1 (RBL-1) cells, and a preventive action on NADPH dependent lipid peroxidation induced by Fe3+-ADP in rat liver microsomes. In addition, 1-[2-[2-(4-Hydroxy-2,3,5-trimethylphenoxy)ethoxy]-ethyl]-2-(4-meth yl-1-homopiperazino)-1H-benzimidazole difumarate (BOM1006) exhibited a dose dependent suppressive action on 48 h homologous passive cutaneous anaphylaxis (PCA) reaction in rats orally administered the drug.


International Journal of Pharmaceutics | 1997

Mutual effect of egg albumin and fatty acids on bioavailability of dl-α-tocopherol

Teruko Imai; Katsuhiko Nodomi; Mohammed Shameem; Hitoshi Matsumoto; Toshio Satoh; Masaki Otagiri

Abstract We studied the dissolution behavior and oral absorption of dl-α-tocopherol (VE) from solid dispersions of egg albumin in the presence or absence of a series of saturated fatty acids. The solubility diagram of VE–egg albumin was of the Bs-type. The solubility of VE was increased by 300-fold in the presence of egg albumin. The egg albumin complex of the drug was obtained in a molar ratio of 20:1 (VE:egg albumin) from the aqueous solubility diagram. The apparent dissolution rate of VE from solid dispersion with egg albumin was markedly enhanced in comparison with VE alone. Addition of various fatty acids to VE–egg albumin solid dispersions had different effects on the dissolution of VE due to mutual effect of fatty acid and egg albumin. Myristic acid was found to improve the dissolution of VE maximally, while capric acid decreased the solubility of VE obtained from egg albumin solid dispersion. The mean serum levels of VE following oral administration of egg albumin solid dispersions, especially egg albumin solid dispersion containing myristic acid, were significantly higher than those of the drug alone. No significant differences were found between the mean residence times of drug and its solid dispersions. In addition, degradation of VE was inhibited by dispersion in egg albumin.


Chemical & Pharmaceutical Bulletin | 1992

Inhibitory Effects of Some Natural Products on the Activation of Hyaluronidase and Their Antiallergic Actions

Hisao Kakegawa; Hitoshi Matsumoto; Toshio Satoh


Biological & Pharmaceutical Bulletin | 1997

Evaluation of Propolis. I. Evaluation of Brazilian and Chinese Propolis by Enzymatic and Physico-Chemical Methods

Hideki Miyataka; Mayumi Nishiki; Hitoshi Matsumoto; Takunori Fujimoto; Mitsuo Matsuka; Toshio Satoh


Biological & Pharmaceutical Bulletin | 1994

Protective Effects of Hydroxychalcones on Free Radical-Induced Cell Damage

Satoshi Sogawa; Yasunori Nihro; Hiroki Ueda; Tokutaro Miki; Hitoshi Matsumoto; Toshio Satoh


Chemical & Pharmaceutical Bulletin | 1994

Synthesis and Anti Lipid-Peroxidation Activity of Hydroquinone Monoalkyl Ethers

Yasunori Nihro; Haruhiro Furukawa; Satoshi Sogawa; Tzer Chuan Wang; Hideki Miyataka; Hitoshi Matsumoto; Tokutaro Miki; Toshio Satoh


Chemical & Pharmaceutical Bulletin | 1991

3-O-Alkuylascorbic Acids as Free Radical Quenchers. II. Inhibitory Effects on Some Lipid Peroxidation Models

Yasunori Nihro; Satoshi Sogawa; Tadamitsu Sudo; Tokutaro Miki; Hitoshi Matsumoto; Toshio Satoh


Biological & Pharmaceutical Bulletin | 1996

Pharmaceutical properties of freeze-dried formulations of egg albumin, several drugs and olive oil.

Yasuhiro Tsuji; Hisao Kakegawa; Hideki Miyataka; Mayumi Nishiki; Hitoshi Matsumoto; Toshio Satoh


Journal of Pharmaceutical Sciences | 2005

Effect of Piceatannol in Human Monocyte-Derived Dendritic Cells In Vitro

Masao Takei; Akemi Umeyama; Shigenobu Arihara; Hitoshi Matsumoto


Chemical & Pharmaceutical Bulletin | 1994

Synthesis of 4-Alkoxyaryl β-D-Glucopyranosides and Their Inhibitory Effects on Histamine Release from Rat Peritoneal Mast Cells Induced by Concanavalin A

Tzer Chuan Wang; Haruhiro Furukawa; Yasunori Nihro; Hisao Kakegawa; Hitoshi Matsumoto; Toshio Satoh

Collaboration


Dive into the Hitoshi Matsumoto's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Hisao Kakegawa

Tokushima Bunri University

View shared research outputs
Top Co-Authors

Avatar

Hideki Miyataka

Tokushima Bunri University

View shared research outputs
Top Co-Authors

Avatar

Tzer Chuan Wang

Tokushima Bunri University

View shared research outputs
Top Co-Authors

Avatar

Yasunori Nihro

Tokushima Bunri University

View shared research outputs
Top Co-Authors

Avatar

Hiroki Ueda

Tokushima Bunri University

View shared research outputs
Top Co-Authors

Avatar

Mayumi Nishiki

Tokushima Bunri University

View shared research outputs
Top Co-Authors

Avatar

Satoshi Sogawa

Tokushima Bunri University

View shared research outputs
Top Co-Authors

Avatar

Tetsuyuki Ikeda

Tokushima Bunri University

View shared research outputs
Top Co-Authors

Avatar

Tokutaro Miki

Tokushima Bunri University

View shared research outputs
Researchain Logo
Decentralizing Knowledge